Impact of Phase 2b strategies on optimization of drug development programs

Christopher Jennison, Zoran Antonijevic, Jim Bolognese, Carl-Fredrik Burman, Christy Chuang-Stein, Martin Kimber, Olga Marchenko, Nitin Patel, Jose Pinheiro

Research output: Chapter or section in a book/report/conference proceedingChapter or section

Original languageEnglish
Title of host publicationOptimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy
Place of PublicationHeidelberg
ISBN (Electronic)978-3-319-09075-7
ISBN (Print)978-3-319-09074-0
Publication statusPublished - 2015

Cite this